Concepedia

Xue-Ling Su

XS

Statistics

Publications

4

Citations

97

H-Index

4

Active since

2020

Affiliations

Zhengzhou University(Current)

Xue-Ling Su is an author at Zhengzhou University specializing in life sciences, nlrp3 inflammasome, and cardiology.

Publications per year

2020–2022

4

Publications

4

GSK-3β-mediated activation of NLRP3 inflammasome leads to pyroptosis and apoptosis of rat cardiomyocytes and fibroblasts

Shuhui Wang, Liu-Gen Cui, Xue-Ling Su et al. · European Journal of Pharmacology · 2022 · 37 citations

, , +15

Glycogen synthase kinase-3β inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction

Shuhui Wang, Xue-Ling Su, Lina Xu et al. · Journal of Molecular and Cellular Cardiology · 2020 · 26 citations

, , +16

The caspase-1 inhibitor VX765 upregulates connexin 43 expression and improves cell–cell communication after myocardial infarction via suppressing the IL-1β/p38 MAPK pathway

Xue-Ling Su, Shuhui Wang, Sumra Komal et al. · Acta Pharmacologica Sinica · 2022 · 24 citations · Full text

, , +16

Glycogen synthase kinase 3 beta inhibitor SB216763 improves Kir2.1 expression after myocardia infraction in rats

Cheng Chang, Shuhui Wang, Lina Xu et al. · Journal of Interventional Cardiac Electrophysiology · 2021 · 10 citations

, , +13

1–4 of 4